Dyadic Logo Current.jpg
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
12 nov. 2024 16h05 HE | Dyadic International, Inc.
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
Dyadic Logo Current.jpg
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
04 nov. 2024 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Logo Current.jpg
Dyadic Expands Global Presence with Participation in Key Industry Events
09 oct. 2024 08h00 HE | Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...
Dyadic Logo Current.jpg
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
23 sept. 2024 09h50 HE | Dyadic International, Inc.
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient,...
Dyadic Logo Current.jpg
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
21 mars 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Logo Current.jpg
Dyadic Announces Collaboration to Commercialize Animal-Free Alternative Proteins Using Dapibus™
08 mai 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Global Lactoferrin Market
Worldwide Lactoferrin Industry to 2030 - Featuring Pharming, Synlait Milk, Metagenics and Glanbia Among Others
25 août 2022 04h38 HE | Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Lactoferrin Market - Market Size & Forecasting to 2030" report has been added to ResearchAndMarkets.com's offering. This research report...
22157.jpg
Global Lactoferrin Market (2021 to 2027) - by Function, Application and Region
21 janv. 2022 06h38 HE | Research and Markets
Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Lactoferrin Market By Function, By Application, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027" report has been...
22157.jpg
Global Lactoferrin Market to 2027 - Industry Analysis, Trends, Market Size, and Forecasts
31 déc. 2021 06h23 HE | Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Lactoferrin market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Lactoferrin Market (2021 to 2028) - Featuring ProHealth, Farbest Brands and InVitria Among Others
24 nov. 2021 07h18 HE | Research and Markets
Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Lactoferrin Market Size, Share & Trends Analysis Report by Function (Iron Absorption, Intestinal Flora Protection), by Application (Personal...